Cofoe Medical Technology Co.,Ltd. (SHE:301087)
53.35
+1.00 (1.91%)
At close: Apr 29, 2026
Cofoe Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Market Capitalization | 12,051 | 9,077 | 7,192 | 7,791 | 7,606 | 12,626 | Upgrade
|
| Market Cap Growth | 73.14% | 26.21% | -7.68% | 2.43% | -39.76% | - | Upgrade
|
| Enterprise Value | 10,475 | 7,390 | 5,460 | 5,861 | 5,337 | 12,682 | Upgrade
|
| Last Close Price | 52.35 | 43.74 | 32.89 | 33.57 | 31.52 | 50.78 | Upgrade
|
| PE Ratio | 28.92 | 24.43 | 23.07 | 30.64 | 25.21 | 29.44 | Upgrade
|
| PS Ratio | 3.56 | 2.68 | 2.41 | 2.73 | 2.56 | 5.55 | Upgrade
|
| PB Ratio | 2.46 | 1.85 | 1.50 | 1.59 | 1.51 | 2.54 | Upgrade
|
| P/TBV Ratio | 2.86 | 2.15 | 1.71 | 1.76 | 1.68 | 2.69 | Upgrade
|
| P/FCF Ratio | 23.28 | 17.54 | 13.25 | 378.22 | - | - | Upgrade
|
| P/OCF Ratio | 17.32 | 13.05 | 10.84 | 19.78 | 76.89 | 52.61 | Upgrade
|
| EV/Sales Ratio | 3.09 | 2.18 | 1.83 | 2.05 | 1.79 | 5.57 | Upgrade
|
| EV/EBITDA Ratio | 20.28 | 16.47 | 13.26 | 19.94 | 18.26 | 28.20 | Upgrade
|
| EV/EBIT Ratio | 31.31 | 22.09 | 17.65 | 27.87 | 21.24 | 30.13 | Upgrade
|
| EV/FCF Ratio | 20.24 | 14.28 | 10.06 | 284.55 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.17 | 0.19 | 0.13 | 0.09 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 1.60 | 1.60 | 1.92 | 1.85 | 1.32 | 0.48 | Upgrade
|
| Debt / FCF Ratio | 1.60 | 1.60 | 1.66 | 31.11 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.33 | -0.33 | -0.36 | -0.36 | -0.44 | -0.66 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.59 | -3.59 | -4.21 | -6.05 | -7.63 | -7.32 | Upgrade
|
| Net Debt / FCF Ratio | -3.11 | -3.11 | -3.19 | -86.41 | 4.12 | 12.05 | Upgrade
|
| Asset Turnover | 0.52 | 0.52 | 0.47 | 0.45 | 0.49 | 0.60 | Upgrade
|
| Inventory Turnover | 2.42 | 2.42 | 2.27 | 2.87 | 3.64 | 2.94 | Upgrade
|
| Quick Ratio | 1.85 | 1.85 | 2.27 | 2.70 | 2.83 | 5.74 | Upgrade
|
| Current Ratio | 2.41 | 2.41 | 2.88 | 3.53 | 3.54 | 6.62 | Upgrade
|
| Return on Equity (ROE) | 7.63% | 7.63% | 6.43% | 5.09% | 6.04% | 14.40% | Upgrade
|
| Return on Assets (ROA) | 3.20% | 3.20% | 3.05% | 2.08% | 2.57% | 6.92% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.21% | 9.15% | 8.38% | 6.28% | 10.14% | 29.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.60% | 6.60% | 6.10% | 4.10% | 4.80% | 8.20% | Upgrade
|
| Earnings Yield | 3.08% | 4.09% | 4.33% | 3.26% | 3.97% | 3.40% | Upgrade
|
| FCF Yield | 4.30% | 5.70% | 7.55% | 0.26% | -7.11% | -2.16% | Upgrade
|
| Dividend Yield | 3.33% | 4.12% | 5.47% | 3.57% | 3.81% | 2.42% | Upgrade
|
| Payout Ratio | 100.04% | 100.05% | 120.12% | 98.28% | 86.05% | 0.63% | Upgrade
|
| Buyback Yield / Dilution | 0.20% | 0.20% | -0.46% | 1.70% | -26.56% | -5.47% | Upgrade
|
| Total Shareholder Return | 3.53% | 4.31% | 5.01% | 5.28% | -22.75% | -3.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.